Internal Medicine Meeting Recordings
In the United States and around the world, the number of people with diabetes continues to increase, particularly at younger ages and with the increase in rates of overweight and obesity. With longer duration of diabetes, more people develop chronic kidney disease and other microvascular complications as well as cardiovascular disease and stroke. Fortunately, therapeutic options are advancing rapidly, giving greater opportunities to improve the health of our patients, but the complexity of care is also increasing. This Pre-Course, recorded in conjunction with the Internal Medicine Meeting 2023, focuses on the diagnosis of prediabetes and diabetes, including less common forms such as maturity-onset diabetes of the young and latent autoimmune diabetes in adults, and reviews the role of lifestyle interventions as well as appropriate indications and practical use of weight loss medications in patients with overweight and diabetes. The risks and benefits of new insulin and noninsulin pharmacologic therapies are presented, and the role of diabetes medications, cholesterol-lowering agents, and blood pressure control to reduce cardiometabolic risk are thoroughly discussed.
Copyright 2023 American College of Physicians. All Rights Reserved.
CME/MOC:
Up to 7
AMA PRA Category 1 Credits ™ and MOC Points
Expires June 06, 2026
active
Cost:
Discounted to Members
Format:
Video Recordings
Product:
Internal Medicine Meeting Recordings
91ºÚÁÏÍø's Internal Medicine Meeting Recording packages include video and slide presentations from a curated selection of popular and highly rated sessions delivered during or derived from the 91ºÚÁÏÍø Internal Medicine Meeting. Trusted, timely content in general internal medicine and the subspecialties is presented by expert faculty; CME and MOC available.
The following individual(s) disclosed relevant financial relationships with ACCME-defined ineligible companies. No other individuals in control of content have anything to disclose. All relevant financial relationships have been mitigated.
Irl B. Hirsch, MD
Research Grants/Contracts: Dexcome, Inc., Insulet Corporation
Consultantship: Abbott Diabetes Care, Gwave, Roche Diabetes Care, Inc.
Andrea D. Coviello, MD
Consultantship: Intuitive Surgical, Inc., Novo Nordisk
Data & Safety Monitoring: Covance
Cecilia C. Low Wang, MD
Research Grants/Contracts: Dexcom, Inc.
Savitha Subramanian, MD
Research Grants/Contracts: Regeneron Pharmaceuticals, Inc.
Consultantship: Abbott Diabetes Care
Lillian F. Lien, MD
Consultantship: Abbott, Eli Lilly & Co., Medtronic USA, Inc., Merck, Novo Nordisk, Sanofi US Services, Inc., Tandem Diabetes Care, Inc.
The American College of Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Physicians designates this enduring material for a maximum of 7 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Release Date: June 7, 2023
End Date: June 6, 2026